Mason Street Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-14,153
Closed -$217K 87
2020
Q4
$217K Sell
14,153
-56
-0.4% -$711 ﹤0.01% 1402
2020
Q3
$171K Buy
14,209
+57
+0.4% +$541 ﹤0.01% 1380
2020
Q2
$144K Buy
14,152
+1,049
+8% +$10.8K ﹤0.01% 1402
2020
Q1
$137K Hold
13,103
﹤0.01% 1355
2019
Q4
$210K Buy
13,103
+388
+3% +$5.93K ﹤0.01% 1374
2019
Q3
$234K Buy
12,715
+292
+2% +$5.71K ﹤0.01% 1330
2019
Q2
$245K Buy
12,423
+496
+4% +$10.1K 0.01% 1308
2019
Q1
$273K Buy
11,927
+399
+3% +$8.66K 0.01% 1327
2018
Q4
$232K Buy
11,528
+543
+5% +$11.2K 0.01% 1272
2018
Q3
$239K Buy
10,985
+357
+3% +$7.93K ﹤0.01% 1332
2018
Q2
$236K Buy
10,628
+434
+4% +$8.87K 0.01% 1331
2018
Q1
$176K Buy
10,194
+645
+7% +$10.8K ﹤0.01% 1373
2017
Q4
$159K Buy
9,549
+284
+3% +$4.85K ﹤0.01% 1386
2017
Q3
$158K Buy
9,265
+828
+10% +$13.9K ﹤0.01% 1368
2017
Q2
$137K Buy
8,437
+967
+13% +$15.3K ﹤0.01% 1389
2017
Q1
$130K Buy
7,470
+584
+8% +$9.77K ﹤0.01% 1388
2016
Q4
$116K Buy
6,886
+963
+16% +$16.1K ﹤0.01% 1397
2016
Q3
$104K Buy
5,923
+753
+15% +$12.2K ﹤0.01% 1384
2016
Q2
$74K Buy
5,170
+461
+10% +$5.76K ﹤0.01% 1419
2016
Q1
$58K Buy
4,709
+440
+10% +$4.86K ﹤0.01% 1432
2015
Q4
$52K Buy
4,269
+390
+10% +$4.8K ﹤0.01% 1433
2015
Q3
$51K Buy
3,879
+307
+9% +$4.63K ﹤0.01% 1425
2015
Q2
$59K Buy
3,572
+161
+5% +$2.67K ﹤0.01% 1421
2015
Q1
$61K Buy
3,411
+122
+4% +$2.27K ﹤0.01% 1417
2014
Q4
$63K Buy
+3,289
New +$55.7K ﹤0.01% 1803

Other funds holding ANGO

Mason Street Advisors's ANGO Position: Q1 2021 in Review

Mason Street Advisors sold out of AngioDynamics (ANGO) in Q1 2021, closing a stake of 14,153 shares — an estimated $217K sold.

Mason Street Advisors first reported a position in ANGO in Q4 2014 and held it in 25 quarters. The position peaked at $273K in Q1 2019. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2021.

  • Mason Street Advisors reported no remaining AngioDynamics position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 14,153 AngioDynamics shares in Q1 2021, an estimated $217K.
  • Mason Street Advisors first reported a position in AngioDynamics in Q4 2014 and held it in 25 quarters.
  • Mason Street Advisors's AngioDynamics position peaked at $273K in Q1 2019.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.